@article{27d366d1dbdc4377aecb00b13780345d,
title = "Telmisartan and Walking Performance in Peripheral Artery Disease",
author = "Bonaca, {Marc P.} and Connie Hess and Beckman, {Joshua A.}",
note = "Funding Information: Worldwide Clinical Trials, and WraSer Pharmaceuticals and receiving personal fees from Audentes Therapeutics (now Astellas Gene Therapies). Dr Hess reported receiving grants from Amgen, Bayer, and Janssen Pharmaceuticals. Dr Beckman reported receiving personal fees from JanOne Inc, Janssen Pharmaceuticals, and Novartis. Funding Information: reported receiving grants from Abbott Laboratories, Agios Pharmaceuticals, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Amgen, Angionetics, ARCA Biopharma, Array BioPharma, AstraZeneca, Atentiv Health, Audentes Therapeutics (now Astellas Gene Therapies), Bayer, Better Therapeutics, Brigham and Women{\textquoteright}s Hospital, Bristol-Myers Squibb, Cardiol Therapeutics, CellResearch Corporation, Cook Medical, CSL Behring, Eidos Therapeutics, EP Trading Co, Esperion Therapeutics, Everlywell, Faraday Pharmaceuticals, Fortress Biotech, HDL Therapeutics, HeartFlow, Hummingbird Bioscience, Insmed, Janssen Pharmaceuticals, Kowa Research Institute, Lexicon Pharmaceuticals, Merck, Medtronic, Moderna, Novate Medical, Novo Nordisk, Pfizer, PhaseBio Pharmaceuticals, Pharmaceutical Product Development (PPD Inc), Prairie Education and Research, Prothena Corp, Regeneron Pharmaceuticals, Regio Biosciences, Sanifit Therapeutics, Sanofi, Smith and Nephew, Stealth BioTherapeutics, University of Colorado,",
year = "2022",
month = oct,
day = "4",
doi = "10.1001/jama.2022.14912",
language = "English (US)",
volume = "328",
pages = "1302--1303",
journal = "JAMA",
issn = "0098-7484",
publisher = "American Medical Association",
number = "13",
}